Mechanisms of protein aggregation and inhibition – Axel Abelein group

Protein misfolding and formation of cross-β structured amyloid fibrils are linked to many neurodegenerative disorders but are also the building blocks of novel biomaterials. Our research aims to understand the underlying mechanisms of amyloid formation to both find treatment strategies against dementia diseases, in particular Alzheimer’s and Parkinson’s disease, and to develop new protein-based materials.

Part of the:

Publications

Selected publications